The corollary to this is that PR3-ANCA positive kidney disease may be more refractory in nature compared with MPO-ANCA positive kidney disease of similar severity as evident by less substantive improvements (with respect to patient numbers and absolute change in eGFR) in kidney function between diagnosis and 12 months irrespective of baseline KDIGO stage. The gene discussed is MPO; the disease is kidney disorder.